The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group Ltd., Becton, Dickinson & Co., Sigma-Aldrich Co. LLC., Corning Life Sciences B.V., EMD Millipore, PromoCell GmbH, and Wheaton Industries Inc. According to a TMR analyst, mergers and acquisitions among the key players are expected to strengthen the market in the coming years.
Cell Culture Consumables Register Higher Demand than Serums and Reagents
The market players are registering increased demand for cell culture across the medical research sector. Cell cultures are being increasingly applied across drug screening and monitoring, disease diagnosis, biologic manufacturing, IVF technology, cancer research, and stem cell research. Increased investments by private medical organizations and government organizations have supported the growth of the global cell culture market. TMR states that among the cell culture consumables, cell culture media register the highest demand compared to serums and reagents. This is due to the key importance of the nature of the culture medium to the health of the cells.
This 127 page report gives readers a comprehensive overview of the cell culture market. Browse through 12 data tables and 49 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/cell-culture-market.html
3D Cell Culture to Define Future of Global Cell Culture Market
The growing demand for biopharmaceuticals and artificial organs, coupled with the emerging trend towards serum-free, customized and specialty media solutions is the primary factor contributing towards the growth of the global cell culture market. The increasing focus on stem cell research would further expand the scope of the market in future. TMR recommends that the focus on backward integration to conduct in-house research and sustaining pricing pressures amid a weak global economic scenario will open up significant opportunities for the market players.
However, ethical concern over the usage of animal sources in cell culture is one of the major restraints in the growth of the market. The usage of transgenic plants and animals, and stringent process controls will also impede the growth of the market in the years to come. “3D cell culture has the potential to serve as the future growth opportunity for the market and in vitro analysis.” a TMR analyst predicts.
Request a sample of this report to know what opportunities will emerge in the rapidly evolving cell culture market during 2014 – 2022: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Asia Pacific to Register Highest Demand for Cell Culture
TMR predicts that among the key regions in the global cell culture market, Asia Pacific will register the fastest growth during the period between 2014 and 2022. “The improvement in economic conditions of the developing countries in the Asia Pacific region such as China and India is anticipated to support the market’s growth,” the analyst states. In 2013, North America was the leading region in the market.
TMR finds that the various opportunities in the global cell culture market will propel the expansion of the market at a CAGR of 7.1% during the period from 2014 to 2022. This would lead to an increase in the valuation of the market from US$6.1 bn in 2013 to US$11.3 bn in 2022.
The review is based on the conclusions of a TMR report titled “Cell Culture Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022.”